Skip to main content

Low-grade intracranial meningioma with bilateral pulmonary metastases incidentally detected postpartum: a case report and review of the literature



Meningiomas are the most commonly encountered intracranial tumors, usually showing indolent behavior. Extra-axial spreading and distant metastases are seldom detected in these tumors, and lung metastasis from a low-grade meningioma is a rare event.

Case presentation

This case report aimed to present the clinical, imaging, and pathological features of a 37-year-old Caucasian pregnant woman with bilateral lung metastases incidentally detected during preoperative workup ahead of surgery for a primary intracranial meningioma. The possible metastatic routes and risk factors of dissemination to the pulmonary circulation were discussed as well.


Metastasis must be considered in patients with intracranial meningiomas accompanied by venous sinus invasion and extension through the calvarium. Thorough paraclinical investigations are suggested in such cases.

Peer Review reports


Meningiomas are extra-axial tumors that are derived from the meningothelial cells of the arachnoid membrane. They are the most common types of primary brain tumor, and females are affected more than males, with a 2:1 ratio. Ionizing radiation and genetic syndromes such as neurofibromatosis type 2 (NF2) have been considered as the risk factors for meningiomas.

Meningiomas are mainly slow-growing. However, they can be aggressive or may even undergo malignant transformation in a small proportion of cases [1, 2]. According to the 2016 classification of central nervous system tumors by the World Health Organization (WHO), meningiomas are classified into three grades; that is, I, II (atypical), and III (malignant). It has been reported that, in the course of the disease, 0.1–1% of all primary meningiomas develop metastases, with the lung being the most frequent site of distant metastatic spread [1,2,3]. The present study aims to report the case of a pregnant patient with bilateral metastatic pulmonary lesions incidentally detected ahead of resection of the primary brain meningioma.

Case presentation

A 37-year-old Caucasian female presented at 18 weeks of gestation with the complaint of a slow-growing scalp mass. She had no history of headaches, blurred vision, nausea, or vomiting. In her past medical history, she had two pregnancies with no complications. On palpation, a well-defined round-to-oval mass was detected with hard consistency. However, the physical examination was unremarkable. Her full-term baby was delivered via cesarean section without any fetal or maternal complications. One month postpartum, the patient was visited by a general surgeon and a tissue biopsy was obtained from the scalp mass. The pathology result was in favor of a grade I meningioma with skull bone involvement. Hence, the patient was referred to the neurosurgery ward. Therein, a brain magnetic resonance imaging (MRI) was done, and an extra-axial 39 × 33 × 25 mm mass isointense in T1, hyperintense in T2, was noted high in the parafalcine region of the left parietal lobe. The mass had a dural tail appearance. Adjacent hyperostosis and enhancement of the adjacent involved calvarium in the high parietal scalp were mentioned as well. The findings were suggestive of an intraosseous meningioma with both intra- and extracranial components (Fig. 1).

Fig. 1.

Preoperative magnetic resonance imaging of the patient with intracranial meningioma, showing a homogeneously enhancing tumor in the parasagittal region: (A1, A2) axial, (B1, B2) sagittal, and (C) coronal views

The patient’s brain meningioma was operated in the neurosurgery department. Right frontoparietal craniotomy was performed, and the tumor was released from the brain tissue ahead of the gross total resection of the mass as well as the involved scalp. The postoperative pathology result of the brain mass was also in favor of grade I/III meningioma. The patient was discharged from the hospital with no complications and no adjuvant cranial radiotherapy.

During the preoperative workup ahead of brain surgery, bilateral lung masses were detected as an incidental finding on chest X-ray and high-resolution computed tomography (HRCT) scan (Figs. 2, 3). There was no history of cough, chest pain, hemoptysis, or difficulty breathing. Heart and lung physical examinations were unremarkable. Preoperative laboratory evaluation including routine complete blood tests, electrocardiogram, and spirometry were unremarkable as well.

Fig. 2.

Chest X-ray showing bilateral intraparenchymal lung lesions

Fig. 3.

Chest CT scan of the lung mass (lateral view). Two well-defined lung masses are apparent

A wedge resection of the left lobe lesion (4 × 5 cm) was performed along with a Tru-Cut biopsy of a pleural-based mass in the right lower pulmonary lobe. The histological feature of the lung tumor was the same as that of the brain mass, and the diagnosis of metastatic meningioma was confirmed by immunohistochemistry (IHC). Accordingly, the tumor cells were positive for EMA, PR, and Ki67 (low) and negative for P63, TTF1, and chromogranin (Figs. 4, 5). Bilateral lesions were resected through staged thoracotomy with no postoperative complications. The patient did not require radiotherapy and chemotherapy. She was followed up via brain and chest CT scans after 2 months, revealing satisfactory residual respiratory function and no evidence of pulmonary relapse.

Fig. 4.

Histopathology of the resected brain mass and the pulmonary lesion showing tumoral cells with whorled appearance without atypia and mitotic figures compatible with meningioma grade I (A). The same pattern is obvious in the lung (B) (hematoxylin and eosin ×100)

Fig. 5.

Immunohistochemical staining showing tumor cells positive for epithelial membrane antigen (A) and progesterone receptor (B) (×100)


Meningioma is a common primary slow-growing, intracranial, extra-axial neoplasm with attachment to the dura mater. It is composed of neoplastic meningothelial cells, and its usual growth rate is less than 1 cm/year, ranging from 0.03 to 2.62 cm/year [4]. Metastases may develop in less than 0.1% of patients, and lungs, liver, lymph nodes, and bones are the most common sites [5]. Pregnancy has been found to be associated with an increased incidence of symptomatic meningiomas in females, suggesting an increased tumor growth during this period [6]. On the other hand, attenuation of clinical symptoms and shrinkage of tumors have been reported during the postpartum period [2, 7].

Estrogen, progesterone, and prolactin levels are elevated during pregnancy, and the expression of the estrogen receptor (ER) and progesterone receptor (PR) has been found in a significant percentage of meningiomas [8]. These findings suggest that female sex hormone-induced cell proliferation is the simplest explanation for the growth of meningioma during pregnancy. On the other hand, exogenous estrogen therapy has not been associated with an increased risk of meningioma, and no change has been detected in the tumor size during the follicular phase of menstruation when estrogen levels are highest [8, 9].

Lusis et al. conducted a study on the pathology specimen of meningiomas during pregnancy and disclosed that the frequency of PR positivity was similar to that of the control group [10]. Although PR expression was found in 70–95% of meningiomas, the same level of expression was observed in tumoral tissues of children and males with minimal progesterone levels [10, 11]. Additionally, the grade of meningioma did not change during pregnancy [10].

Recently, Telugu et al. explored the expressions of ER and PR in meningioma specimens via IHC and assessed their correlations with gender, histological subtypes, and grade. The expression rates of ER and PR were 2% and 66%, respectively. No significant correlation was detected between the positivity of PR and the above-mentioned variables [12]. Therefore, the levels of sex hormones and expressions of receptors in tumoral tissues alone cannot justify the growth of meningiomas during pregnancy.

Another hypothesis that prevails to date is that meningioma growth is associated with vascular changes during pregnancy such as intratumoral hypervascularity and tissue edema [10]. The exact mechanism of edema is unclear, but an increase in the expression of aquaporin (a water channel protein) during pregnancy and a positive effect of progesterone on vascular dilatation have been suggested [10]. It seems that, during pregnancy, due to hemodynamic changes, a preexisting meningioma may present with the clinical symptoms of elevated intracranial pressure, including headache, nausea, and vomiting. After pregnancy, shrinkage of the tumoral tissue may occur and the mass size may decrease on its own.

Although meningiomas are more common among females, metastasis has not been reported to be more common in this population. For instance, multiple pulmonary metastases from preexisting intracranial meningiomas are rare in females. To the best of our knowledge, 33 such cases have been reported in the literature (Table 1) [1, 2, 7, 13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41]. The median age of the patients was 50 years (age range 26–91 years). In addition, the interval between the detection of the primary meningioma and the detection of lung metastases ranged from 9 to 19 years. In two cases, the lung mass was found concurrently with the primary brain tumor. Generally, lung metastases rarely cause symptoms such as cough and hemoptysis. In the present case, bilateral pulmonary nodules were found incidentally and the patient had no respiratory symptoms. The exact mechanism of multiple lung metastases from an intracranial tumor is not clear yet. Higher histological grades (II/III), venous sinus invasion, prior surgery for resection of the primary tumor, and tumor recurrence have been reported as the predictive factors for multiple lung metastases. Dissemination of tumor cells by hematogenous and lymphatic vessels or by cerebrospinal fluid (CSF) seeding have also been suggested as the underlying mechanisms of metastasis [42]. Tumor invasion to dural venous sinuses and cranial veins facilitate the hematogenous spread of tumoral cells to the pulmonary circulation [42]. The present case had a large mass with the invasion of the superior sagittal sinus and extension through the calvarium and scalp. Genetic abnormalities such as loss of heterozygosity at 9p, 1p, and 22q have also been considered the predictors of lung metastases [1].

Table 1. Demographic features, treatment and outcome of reported cases

Surgical resection is the current standard of care for primary low-grade meningiomas. For high-grade lesions, surgical resection is combined with adjuvant radiotherapy to prevent local recurrence. Thoracotomy to surgically excise the lung mass is the treatment of choice for metastatic lung masses. Due to the rarity of metastatic meningiomas, few clinical trials have been performed and no standard treatment is available. Previous studies assessed the efficacy of hydroxyurea, external beam radiation, and sunitinib in treatment of high-grade metastatic cases [43, 44].


In patients with intracranial meningiomas accompanied by venous sinus invasion and extension through the calvarium, metastasis must be considered and thorough paraclinical investigations are suggested. From a practical point of view, these seemingly benign lesions may not be as they appear, which emphasizes the importance of follow-up for such lesions beyond the scope of neurosurgery.

Availability of data and materials

No additional datasets were used for the creation of this manuscript. All information is available from the standard documentation in the patient’s electronic medical record.


  1. 1.

    Vakil H, Tran L, Lewis GD, Cykowski MD, Butler EB, Teh BS. Biopsy proven metastatic meningioma: a case report and review of the literature. Rep Pract Oncol Radiother. 2019;24(6):528–32.

    PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    Wang M, Zhan R, Zhang C, Zhou Y. Multiple pulmonary metastases in recurrent intracranial meningioma: case report and literature review. J Int Med Res. 2016;44(3):742–52.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  3. 3.

    He L, Yu S, Wang L. Rapid recurrence and malignant transformation of a benign meningioma after pregnancy: a case report. Br J Neurosurg. 2020;1:1–3.

    Article  Google Scholar 

  4. 4.

    Yekeler E, Dursun M, Yilmazbayhan D, Tunaci A. Multiple pulmonary metastases from intracranial meningioma: MR imaging findings (case report). Diagn Interv Radiol. 2005;11(1):28–30.

    PubMed  Google Scholar 

  5. 5.

    Kessler RA, Garzon-Muvdi T, Yang W, Weingart J, Olivi A, Huang J, et al. Metastatic atypical and anaplastic meningioma: a case series and review of the literature. World Neurosurg. 2017;101:47–56.

    PubMed  Article  Google Scholar 

  6. 6.

    Pettersson-Segerlind J, Mathiesen T, Elmi-Terander A, Edström E, Talbäck M, Feychting M, et al. The risk of developing a meningioma during and after pregnancy. Sci Rep. 2021;11(1):9153.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  7. 7.

    Erman T, Hanta I, Haciyakupoğlu S, Zorludemir S, Zeren H, Göçer AI. Huge bilateral pulmonary and pleural metastasis from intracranial meningioma: a case report and review of the literature. J Neurooncol. 2005;74(2):179–81.

    PubMed  Article  Google Scholar 

  8. 8.

    Hortobágyi T, Bencze J, Murnyák B, Kouhsari MC, Bognár L, Marko-Varga G. Pathophysiology of meningioma growth in pregnancy. Open Med (Wars). 2017;12:195–200.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  9. 9.

    Laviv Y, Ohla V, Kasper EM. Unique features of pregnancy-related meningiomas: lessons learned from 148 reported cases and theoretical implications of a prolactin modulated pathogenesis. Neurosurg Rev. 2018;41(1):95–108.

    PubMed  Article  Google Scholar 

  10. 10.

    Lusis EA, Scheithauer BW, Yachnis AT, Fischer BR, Chicoine MR, Paulus W, et al. Meningiomas in pregnancy: a clinicopathologic study of 17 cases. Neurosurgery. 2012;71(5):951–61.

    PubMed  Article  Google Scholar 

  11. 11.

    Laviv Y, Ohla V, Kasper EM. Unique features of pregnancy-related meningiomas: lessons learned from 148 reported cases and theoretical implications of a prolactin modulated pathogenesis. Neurosurg Rev. 2018;41(1):95–108.

    PubMed  Article  Google Scholar 

  12. 12.

    Telugu RB, Chowhan AK, Rukmangadha N, Patnayak R, Phaneendra BV, Mowliswara Prasad BC, et al. Estrogen and progesterone receptor in meningiomas: an immunohistochemical analysis. J Cancer Res Ther. 2020;16(6):1482–7.

    CAS  PubMed  Google Scholar 

  13. 13.

    Aumann JL, van den Bosch JM, Elbers JR, Wagenaar SJ. Metastatic meningioma of the lung. Thorax. 1986;41(6):487–8.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  14. 14.

    LeMay DR, Bucci MN, Farhat SM. Malignant transformation of recurrent meningioma with pulmonary metastases. Surg Neurol. 1989;31(5):365–8.

    CAS  PubMed  Article  Google Scholar 

  15. 15.

    Hishima T, Fukayama M, Funata N, Mochizuki M, Hayashi Y, Koike M, et al. Intracranial meningioma masquerading as a primary pleuropulmonary tumor. Pathol Int. 1995;45(8):617–21.

    CAS  PubMed  Article  Google Scholar 

  16. 16.

    Murrah CP, Ferguson ER, Jennelle RL, Guthrie BL, Holman WL. Resection of multiple pulmonary metastases from a recurrent intracranial meningioma. Ann Thorac Surg. 1996;61(6):1823–4.

    CAS  PubMed  Article  Google Scholar 

  17. 17.

    Adlakha A, Rao K, Adlakha H, Perry A, Crotty TB, Scheithauer BW, et al. Meningioma metastatic to the lung. Mayo Clin Proc. 1999;74(11):1129–33.

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Figueroa BE, Quint DJ, McKeever PE, Chandler WF. Extracranial metastatic meningioma. Br J Radiol. 1999;72(857):513–6.

    CAS  PubMed  Article  Google Scholar 

  19. 19.

    Travitzky M, Libson E, Nemirovsky I, Hadas I, Gabizon A. Doxil-induced regression of pleuro-pulmonary metastases in a patient with malignant meningioma. Anticancer Drugs. 2003;14(3):247–50.

    CAS  PubMed  Article  Google Scholar 

  20. 20.

    Psaras T, Pantazis G, Steger V, Meyermann R, Honegger J, Beschorner R. Benign meningioma developing late lung metastases: case report and review of the literature. Clin Neuropathol. 2009;28(6):453–9.

    CAS  PubMed  Article  Google Scholar 

  21. 21.

    Alexandru D, Glantz MJ, Kim L, Chamberlain MC, Bota DA. Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: prognosis and identification by 111Indium-octreotide imaging. Cancer. 2011;117(19):4506–11.

    CAS  PubMed  Article  Google Scholar 

  22. 22.

    Sabet A, Ahmadzadehfar H, Herrlinger U, Wilinek W, Biersack HJ, Ezziddin S. Successful radiopeptide targeting of metastatic anaplastic meningioma: case report. Radiat Oncol. 2011;6:94.

    PubMed  PubMed Central  Article  Google Scholar 

  23. 23.

    Nakayama Y, Horio H, Horiguchi S, Hato T. Pulmonary and pleural metastases from benign meningeal meningioma: a case report. Ann Thorac Cardiovasc Surg. 2014;20(5):410–3.

    PubMed  Article  Google Scholar 

  24. 24.

    Ocque R, Khalbuss WE, Monaco SE, Michelow PM, Pantanowitz L. Cytopathology of extracranial ectopic and metastatic meningiomas. Acta Cytol. 2014;58(1):1–8.

    PubMed  Article  Google Scholar 

  25. 25.

    Frydrychowicz C, Holland H, Hantmann H, Gradistanac T, Hoffmann KT, Mueller W, et al. Two cases of atypical meningioma with pulmonary metastases: a comparative cytogenetic analysis of chromosomes 1p and 22 and a review of the literature. Neuropathology. 2015;35(2):175–83.

    PubMed  Article  Google Scholar 

  26. 26.

    Dalle Ore CL, Magill ST, Yen AJ, Shahin MN, Lee DS, Lucas CG, et al. Meningioma metastases: incidence and proposed screening paradigm. J Neurosurg. 2019;132(5):1447–55.

    PubMed  Article  Google Scholar 

  27. 27.

    Sathirareuangchai S, Kakazu K, Tauchi-Nishi P, Morris P, Sae-Ow W. Low grade intracranial meningioma presenting with pulmonary metastasis: case report and literature review. Pathol Res Pract. 2019;215(7):152390.

    PubMed  Article  Google Scholar 

  28. 28.

    Asioli S, Senetta R, Maldi E, D’Ambrosio E, Satolli MA, Bussolati G, et al. “Benign” metastatic meningioma: clinico-pathological analysis of one case metastasising to the lung and overview on the concepts of either primitive or metastatic meningiomas of the lung. Virchows Arch. 2007;450(5):591–4.

    PubMed  Article  Google Scholar 

  29. 29.

    Baisden BL, Hamper UM, Ali SZ. Metastatic meningioma in fine-needle aspiration (FNA) of the lung: cytomorphologic finding. Diagn Cytopathol. 1999;20(5):291–4.

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Brennan C, O’Connor OJ, O’Regan KN, Keohane C, Dineen J, Hinchion J, et al. Metastatic meningioma: positron emission tomography CT imaging findings. Br J Radiol. 2010;83(996):e259–62.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  31. 31.

    Fabi A, Nuzzo C, Vidiri A, Ciccarese M, Felici A, Cattani F, et al. Bone and lung metastases from intracranial meningioma. Anticancer Res. 2006;26(5b):3835–7.

    PubMed  Google Scholar 

  32. 32.

    Kanzaki R, Higashiyama M, Fujiwara A, Tokunaga T, Maeda J, Okami J, et al. Surgical resection of pulmonary metastases from meningioma: report of a case. Surg Today. 2011;41(7):995–8.

    PubMed  Article  Google Scholar 

  33. 33.

    Kodama K, Doi O, Higashiyama M, Horai T, Tateishi R, Nakagawa H. Primary and metastatic pulmonary meningioma. Cancer. 1991;67(5):1412–7.

    CAS  PubMed  Article  Google Scholar 

  34. 34.

    Kovoor JM, Jayakumar PN, Srikanth SG, Indira B, Devi MG. Solitary pulmonary metastasis from intracranial meningiothelial meningioma. Australas Radiol. 2002;46(1):65–8.

    PubMed  Article  Google Scholar 

  35. 35.

    Lambertz N, Koehler J, Schulte DM, Kuehl H, Wohlschlaeger J, Hense J, et al. Multivisceral systemic metastases from an intracranial anaplastic meningioma: a case report and review of literature. Clin Neurol Neurosurg. 2011;113(7):592–5.

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Pramesh CS, Saklani AP, Pantvaidya GH, Heroor AA, Naresh KN, Sharma S, et al. Benign metastasizing meningioma. Jpn J Clin Oncol. 2003;33(2):86–8.

    CAS  PubMed  Article  Google Scholar 

  37. 37.

    Shin MS, Holman WL, Herrera GA, Ho KJ. Extensive pulmonary metastasis of an intracranial meningioma with repeated recurrence: radiographic and pathologic features. South Med J. 1996;89(3):313–8.

    CAS  PubMed  Article  Google Scholar 

  38. 38.

    Som PM, Sacher M, Strenger SW, Biller HF, Malis LI. “Benign” metastasizing meningiomas. AJNR Am J Neuroradiol. 1987;8(1):127–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Tao CY, Wang JJ, Li H, You C. Malignant intraventricular meningioma with craniospinal dissemination and concurrent pulmonary metastasis. World J Surg Oncol. 2014;12:238.

    PubMed  PubMed Central  Article  Google Scholar 

  40. 40.

    Tao LC. Pulmonary metastases from intracranial meningioma diagnosed by aspiration biopsy cytology. Acta Cytol. 1991;35(5):524–8.

    CAS  PubMed  Google Scholar 

  41. 41.

    Tworek JA, Mikhail AA, Blaivas M. Meningioma: local recurrence and pulmonary metastasis diagnosed by fine needle aspiration. Acta Cytol. 1997;41(3):946–7.

    CAS  PubMed  Google Scholar 

  42. 42.

    Lee GC, Choi SW, Kim SH, Kwon HJ. Multiple extracranial metastases of atypical meningiomas. J Korean Neurosurg Soc. 2009;45(2):107–11.

    PubMed  PubMed Central  Article  Google Scholar 

  43. 43.

    Kim J, Kim KH, Kim YZ. The clinical outcome of hydroxyurea chemotherapy after incomplete resection of atypical meningiomas. Brain Tumor Res Treat. 2017;5(2):77–86.

    PubMed  PubMed Central  Article  Google Scholar 

  44. 44.

    Kaley TJ, Wen P, Schiff D, Ligon K, Haidar S, Karimi S, et al. Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma. Neuro Oncol. 2015;17(1):116–21.

    CAS  PubMed  Article  Google Scholar 

Download references


The authors would like to thank Ms. A. Keivanshekouh at the Research Consultation Center (RCC) of Shiraz University of Medical Sciences for improving the use of English in the manuscript.


None declared.

Author information




NA drafted the article. AA and SP collected the data and participated in drafting the article. PM, AS, MV, and SHY performed the surgical operation, were in charge of the patient’s status, obtained consent, collected the clinical data, and helped draft the manuscript. MHA performed the pathological examination and revised the article. PM and AS equally participated in the management of the case and have been considered as co-first authors. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Negar Azarpira.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Ethics Committee of Namazi Hospital. In addition, written informed consent was obtained from the patient.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and the accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of the journal.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mardani, P., Safarian, A., Ashari, A. et al. Low-grade intracranial meningioma with bilateral pulmonary metastases incidentally detected postpartum: a case report and review of the literature. J Med Case Reports 15, 509 (2021).

Download citation


  • Meningioma
  • Extra-axial metastasis
  • Lung
  • Pregnancy
  • Case report